Form 4: Hims & Hers Health PAO Irene Becklund Reports Sale of Shares and Acquisition of Restricted Stock Units

Irene Becklund, PAO of Hims & Hers Health, reports the sale of 2,203 shares of Class A Common Stock and the acquisition of 22,284 Restricted Stock Units.

Summary

• On March 11, 2025, Irene Becklund, the PAO of Hims & Hers Health, Inc., reported a transaction involving the company's securities.
• Becklund sold 2,203 shares of Class A Common Stock at a price of $34.77 per share.
• Following the sale, Becklund still directly owns 2,203 shares of Class A Common Stock.
• Becklund also acquired 22,284 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Class A Common Stock.
• These RSUs are subject to a 4-year service-based vesting requirement, with vesting occurring in substantially equal quarterly installments starting June 15, 2025.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The RSUs will vest over a 4-year period, starting June 15, 2025, which incentivizes continued service by the reporting person.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring compliance with SEC regulations.
• Vesting schedules for RSUs are common, typically ranging from 3 to 5 years, aligning with industry norms for executive compensation.

Stakeholder Impact

• The sale of shares may have a minor impact on shareholders, but the overall effect is likely minimal given the relatively small number of shares involved.
• The vesting of RSUs incentivizes the PAO to remain with the company, potentially benefiting the company and its stakeholders.

Key Dates